World Antibacterial Therapeutic Market - Opportunities and Forecasts, 2019-2026
|
LI_181442
|
Pages: NA
|
Nov 2019 |
1205 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Antibacterial drugs inhibit bacterial growth for the preventions and treatment of bacterial infections. Antibacterial antibiotic drugs represents the most remarkable portion of antibiotic therapy. The global antibacterial therapeutic market has observed tremendous growth over the past few decades owing to increasing use of antibiotics in the treatment of bacterial infections. However, the misuse or overuse of antibiotics has led to the emergence of resistant strains of bacteria. This represents the unmet market need for innovative antibacterial therapy, as rising number of infections that are complicated to treat, pose a significant public health threat. The major factors such as, increasing research and development investment and a large patient pool, are anticipated to fuel the market growth. Other factors driving the global antibacterial therapeutic market are; rising incidences of infectious diseases, high prevalence of hospital acquired infections, rising disease awareness, public and private initiatives to promote judicious use of antibiotics, improving regulatory framework, large population in the emerging economies with compromised health environment, and the increasing count of geriatric population. However, ambiguous reimbursement scenario, and limited accessibility of drugs in emerging economies are likely to restrict the market growth.
The global antibacterial therapeutic market is segmented on the basis of drug class, drug mechanism, route of administration and geography. According to drug type, the market is segmented into; Penicillins, Cephalosporins, Quinolone, Aminoglycosides, Monobactams, Carbapenems, Macrolides and Others. On the basis of drug mechanism the market is segmented into; Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, Nucleic Acid Inhibitors, Folic Acid synthesis inhibitors and Mycolic Acid synthesis inhibitors. The market is also segmented on the basis of route of administration into oral, topical and parenteral. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA. New product approval is the key strategy adopted by top industry players. For instance, FDA has recently approved Dalvance, an intravenous antibacterial drug intended for the treatment of skin infections caused by Staphylococcus aureus. Similarly in Dec 2014, Cubist Pharmaceuticals, received the FDA approval for Zerbaxa, a combination of ceftolozan and tazobactam antibacterial drugs intended for use in intra-abdominal and urinary tract infections. The companies profiled in this report include, Abbott Laboratories, Daiichi Sankyo Company, Limited, Pfizer, Inc., Takeda Pharmaceutical Company Ltd, Eli Lilly and Company, Novartis AG, Sanofi S.A., AstraZeneca plc, Bayer AG and Merck & Co., Inc.
KEY MARKET BENEFITS:
- Comprehensive analysis of factors that drive and restrict the growth of the global antibacterial therapeutic market is provided
- The report provides a comprehensive analysis of the current market and estimations through 20142020, which would enable the stakeholders to capitalize on prevailing market opportunities
- An in-depth analysis of key segments of the market demonstrate the types of Drug Classes along with along with drug mechanisms and routes of administration in the global antibacterial therapeutic market
- SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
- Region-wise antibacterial therapeutic market scenario is comprehensively analysed in the report
KEY MARKET SEGMENTS:
The global antibacterial therapeutic market is segmented below:
Antibacterial Therapeutic Market By Drug Class
- Penicillins
- Cephalosporins
- Quinolone
- Aminoglycosides
- Monobactams
- Carbapenems
- Macrolides
- Others
Antibacterial Therapeutic Market By Drug Mechanism
- Cell Wall Synthesis inhibitors
- Protein Synthesis inhibitors
- Nucleic Acid inhibitors
- Folic Acid synthesis inhibitors
- Mycolic Acid synthesis inhibitors
Antibacterial Therapeutic Market By Route of Administration
- Oral
- Topical
- Parenteral
- Others
Antibacterial Therapeutic Market By Geography
- North America
- Europe
- Asia-Pacific
- LAMEA
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
World Antibacterial Therapeutic Market- Opportunities and Forecasts, 2019-2026
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in Excel
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited within company/enterprise
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Buy Full Version
"World Antibacterial Therapeutic Market"
Purchase Enquiry